Welcome to the Extreme Investor Network, where we bring you the latest and greatest insights into the world of investing. Today, we’re diving into Oppenheimer’s spotlight on several stocks that are set to gain momentum over the next 12 months.
Historically, September has been a tough month for stocks, with the S & P 500 averaging a loss of 0.7% since 1950. However, this September has been different, with the broad market index, Nasdaq Composite, and Dow Jones Industrial Average all seeing gains. This positive trend follows a four-month winning streak for the S & P.
Oppenheimer has curated a list of its 32 best stock ideas for October, all of which have an outperform rating. Some notable additions to the list include DraftKings, a top idea expected to capture a significant market share in the sports betting industry. With a strong track record in daily fantasy sports, DraftKings is poised to become a key player in the U.S. sports betting market.
Biotechnology stock Viking Therapeutics also made the cut, with an outperform rating and a target price implying over 118% upside potential. The company’s experimental obesity treatment is progressing well through clinical trials, positioning it as a potential leader in the market.
Telecommunications stock AT & T is another best idea on Oppenheimer’s list, with an analyst viewing its high dividend yield as attractive. With the potential for unique integration of services and cost-saving virtualized technologies, AT & T is set for growth in the coming months.
In addition to these names, Oppenheimer’s list includes Cigna and chip giant Broadcom, both of which have strong upside potential based on analyst targets.
Stay tuned to Extreme Investor Network for more exclusive insights and in-depth analysis on the hottest investment opportunities in the market. Make sure to bookmark our page for the latest updates on stocks, trends, and strategies to maximize your investment portfolio.